Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06159842 · ClinicalTrials.gov registry record · Phase 2
Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (isSCC)
A Phase 2 study, sponsored by The Center for Clinical and Cosmetic Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 32
- Enrollment target
NCT06159842: Completed Phase 2 study, sponsored by The Center for Clinical and Cosmetic Research.
NCT06159842 is a Phase 2 study that has completed, run by The Center for Clinical and Cosmetic Research. The registered enrollment target is 32 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (76% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06159842, a Phase 2 study, has completed, sponsored by The Center for Clinical and Cosmetic Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 32 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to test how safe and effective it is to treat early form of cancer cells found in the upper skin layer of the face, using a light-sensitive cream used in combination with a light source. The main questions this trial aims to answer are: * to confirm using laboratory testing, how much of the affected facial skin cancer section the treatment was able to remove, and; * seeing how many participants had no remaining affected facial skin cancer sections after treatment. Participants who qualify will be asked to complete 12 visits in total and will receive a total of two treatments, after voluntarily consent has been given.
Primary Outcome
Histological clearance is defined as the absence of detectable evidence of isSCC tumor cell nests by the central pathology reports
Interventions
- COMBINATION_PRODUCT Aminolevulinic Acid 20% Topical Solution with Blue Light
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2023-08-08 |
| Est. Completion | 2024-11-13 |
| Phase | Phase 2 |
What the finished NCT06159842 record still lists
NCT06159842 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (76% lower).
The record links to 0 conditions, and to 1 intervention - of which Aminolevulinic Acid 20% Topical Solution with Blue Light is the first listed.
NCT06159842 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06159842 about?
NCT06159842 is a clinical study titled "Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (isSCC)". The goal of this clinical trial is to test how safe and effective it is to treat early form of cancer cells found in the upper skin layer of the face, using a light-sensitive cream used in combination with a light source. The main questions this trial aims to answer are: * to confirm using laborat...
What is the current status of trial NCT06159842?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 32 participants. The study started on 2023-08-08. Estimated completion is 2024-11-13.
What interventions are being tested in trial NCT06159842?
The interventions under investigation include: Aminolevulinic Acid 20% Topical Solution with Blue Light (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT06159842?
This trial is sponsored by The Center for Clinical and Cosmetic Research, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06159842's enrollment target sits among peer trials
32 1563rd of 2000 higher than 423 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI